IBDEI1C2 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23890,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23890,1,2,0)
 ;;=2^593.70
 ;;^UTILITY(U,$J,358.3,23890,1,5,0)
 ;;=5^VUR w/o Nephropathy Unspec
 ;;^UTILITY(U,$J,358.3,23890,2)
 ;;=^303304
 ;;^UTILITY(U,$J,358.3,23891,0)
 ;;=593.71^^153^1524^45
 ;;^UTILITY(U,$J,358.3,23891,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23891,1,2,0)
 ;;=2^593.71
 ;;^UTILITY(U,$J,358.3,23891,1,5,0)
 ;;=5^VUR w/ Reflux Nephropathy Unilat
 ;;^UTILITY(U,$J,358.3,23891,2)
 ;;=^303302
 ;;^UTILITY(U,$J,358.3,23892,0)
 ;;=593.72^^153^1524^43
 ;;^UTILITY(U,$J,358.3,23892,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23892,1,2,0)
 ;;=2^593.72
 ;;^UTILITY(U,$J,358.3,23892,1,5,0)
 ;;=5^VUR w/ Reflux Nephropathy Bilat
 ;;^UTILITY(U,$J,358.3,23892,2)
 ;;=^303303
 ;;^UTILITY(U,$J,358.3,23893,0)
 ;;=593.73^^153^1524^44
 ;;^UTILITY(U,$J,358.3,23893,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23893,1,2,0)
 ;;=2^593.73
 ;;^UTILITY(U,$J,358.3,23893,1,5,0)
 ;;=5^VUR w/ Reflux Nephropathy NOS
 ;;^UTILITY(U,$J,358.3,23893,2)
 ;;=^303305
 ;;^UTILITY(U,$J,358.3,23894,0)
 ;;=403.90^^153^1524^20
 ;;^UTILITY(U,$J,358.3,23894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23894,1,2,0)
 ;;=2^403.90
 ;;^UTILITY(U,$J,358.3,23894,1,5,0)
 ;;=5^HTN Chr Renal Disease,Stages I-IV
 ;;^UTILITY(U,$J,358.3,23894,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,23895,0)
 ;;=403.91^^153^1524^19
 ;;^UTILITY(U,$J,358.3,23895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23895,1,2,0)
 ;;=2^403.91
 ;;^UTILITY(U,$J,358.3,23895,1,5,0)
 ;;=5^HTN Chr Renal Disease Stage V-ESRD
 ;;^UTILITY(U,$J,358.3,23895,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,23896,0)
 ;;=585.9^^153^1524^12
 ;;^UTILITY(U,$J,358.3,23896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23896,1,2,0)
 ;;=2^585.9
 ;;^UTILITY(U,$J,358.3,23896,1,5,0)
 ;;=5^Chr Kidney Disease/Failure
 ;;^UTILITY(U,$J,358.3,23896,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,23897,0)
 ;;=586.^^153^1524^38
 ;;^UTILITY(U,$J,358.3,23897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23897,1,2,0)
 ;;=2^586.
 ;;^UTILITY(U,$J,358.3,23897,1,5,0)
 ;;=5^Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,23897,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,23898,0)
 ;;=584.9^^153^1524^39
 ;;^UTILITY(U,$J,358.3,23898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23898,1,2,0)
 ;;=2^584.9
 ;;^UTILITY(U,$J,358.3,23898,1,5,0)
 ;;=5^Renal Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,23898,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,23899,0)
 ;;=585.1^^153^1524^7
 ;;^UTILITY(U,$J,358.3,23899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23899,1,2,0)
 ;;=2^585.1
 ;;^UTILITY(U,$J,358.3,23899,1,5,0)
 ;;=5^Chr Kidney Disease Stage I
 ;;^UTILITY(U,$J,358.3,23899,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,23900,0)
 ;;=585.2^^153^1524^8
 ;;^UTILITY(U,$J,358.3,23900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23900,1,2,0)
 ;;=2^585.2
 ;;^UTILITY(U,$J,358.3,23900,1,5,0)
 ;;=5^Chr Kidney Disease Stage II
 ;;^UTILITY(U,$J,358.3,23900,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,23901,0)
 ;;=585.3^^153^1524^9
 ;;^UTILITY(U,$J,358.3,23901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23901,1,2,0)
 ;;=2^585.3
 ;;^UTILITY(U,$J,358.3,23901,1,5,0)
 ;;=5^Chr Kidney Disease Stage III
 ;;^UTILITY(U,$J,358.3,23901,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,23902,0)
 ;;=585.4^^153^1524^10
 ;;^UTILITY(U,$J,358.3,23902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23902,1,2,0)
 ;;=2^585.4
 ;;^UTILITY(U,$J,358.3,23902,1,5,0)
 ;;=5^Chr Kidney Disease Stage IV
 ;;^UTILITY(U,$J,358.3,23902,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,23903,0)
 ;;=585.5^^153^1524^11
 ;;^UTILITY(U,$J,358.3,23903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23903,1,2,0)
 ;;=2^585.5
